1. Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
- Author
-
Elshaer, Amani, Chascsa, David M. H., and Lizaola-Mayo, Blanca C.
- Subjects
- *
WEIGHT loss , *LIVER diseases , *REGULATION of body weight , *BARIATRIC surgery , *FATTY degeneration - Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD continues to rise, leading to increased patient risk of various complications. Recent research has been focused on new therapeutic strategies to reduce the incidence of MASLD and provide effective treatment plans to prevent further irreversible liver damage. The treatment approach is multifactorial, with a primary focus on weight loss and management of underlying comorbidities through lifestyle modifications, pharmacotherapy, or surgical options. Ongoing research is exploring new pharmacological therapies that could enhance the treatment of MASLD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF